{"ticker": {"uuid": "fe76aab6-ad9d-4e65-bdc8-d9894d727f63", "symbol": "BLCO", "name": "Bausch + Lomb Corporation", "exchange": "TOR", "country": "CA", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "How Investors May Respond To Bausch + Lomb (BLCO) Expanding Ophthalmic Tools With EyeGility And Orphia AI", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-16T22:03:59+00:00", "published_display": "16 Jul 2026 22:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch + Lomb Corporation (BLCO) and Intellia Therapeutics (NTLA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgJBVV95cUxNTmhUeWZQRUVHWmlGVEdhLTdiUzUwbHd0aUN5OTljT2ZwWFVZa1NzVHJELVZuNU1ILV9feFItLXBtSElNZzY0elpSNUhKMXRnRENmamJGTElzNFloWFdYdlhwd05mSldpZ0JMaXFndHB5SHF0Z3owT1Z6QzdmRXJzRUZOTkNqWVJlbjRWbGdYX3RMNDRvNTVFZkhvMVh3UXNfbWc3NF9aanlPVzlYZVQ1a1I4UmQxOGhlS1RlYkhjdFozYTgtWXBCdVNtM2pTd2dNR3o1TlliRVd6dEVPUEZRMlBTM3pEWG9JUjNnbUdmRXhSdlN6eUZ3LVliZUdBZWtiemNuQlZaMmEzN1hWSEg3NEpORWFwZmNRWDJmTG1yYW5KdXZYRGtHRXRnclMwWmw0Z1NFTDZB?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-16T21:38:00+00:00", "published_display": "16 Jul 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $21", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQm9mSnZfcnNYZFRIcDhwWDdwUFQ4cU5fcDgtY2g3WTFHMlJkU2R4VktMWnA4d0NnTW5uRkpnTzYtM3RBVm5tblpWMEctM2pBUUhtV2hMNENfMkhZYXBCRGw3ZUVNWlZzbkFpcWd4Znl5Z0h0OTBIanlPZ1M1eENQUl9Bdk5wWElOX2tlT1hoaGFBdWxxSlpMTG1KR3ctRWJxbzVFRWg0X0x1QQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-15T21:31:00+00:00", "published_display": "15 Jul 2026 21:31", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb Corporation (BLCO) Stock Analysis: Examining a Healthcare Leader with 11.68% Potential Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxONjRqQVcyQ3ZUMHRIQjhoRjZ0WFdCLVoxR3lkV2lDV1R3RGdkQ2Y2WVpiNDltaWJYdk1CYTY4S2RKQ1R0VGtsLXR1VEprdy1UVFpTaVctTVdrQmtob3BNRVJHZWdoa0kyX2gyQ2ZXT2hwNS1rRy05V1RmcndWdU9IRGtaaE0wbjYzeUF2SzdjMEJnVDZKbmlldVZvOFFiYnFKaHdFSlp0TllEWlp0RVFXVjRxMVlCREVTbDJaOGNUd3JsSDY2aTY4Z19MZmh3c09XNnB4dlVqcjNrNldGSUluTFkzWjlCdEE?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:23:43+00:00", "published_display": "13 Jul 2026 09:23", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPYmtwbXNJUjlRc0owMHd3MDBQOFFhM1ppZWZmSkZVTVV0M1NVdDRKS2s5SDdaQndDZk81WHRXNTNZNGNVSHNPbVBQdURxdGhQSUxsLXRRRnZMZC1rSS1qXzMyUlFocTZ6TFA2OGNYSDBVeUtGUnpJWG1CZlRLV2U5ZmE0bWhIUGtmOXh6bExjZUlCanZJQ3c?oc=5", "source_name": "Market source", "published_at": "2026-07-10T21:27:20+00:00", "published_display": "10 Jul 2026 21:27", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BLCO Stock Drops After-Hours \u2014 Bausch + Lomb Halts Glaucoma Eye Drop Program After Trial Failure", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQcVR2TktPdTV5TFB1LXBsS0FiVklodV9kZlZsc0U1QTNyQ2dvT2lXa1NIZFlVRTZORGFDS21rNll4bDM2SC1GdWlXcm45TENtQnUwcVAyd1NwVnA0V1VmM255OXBwZUNGQmItWEMyakJsYnJxaDNoWUFud25XQzdiVldkZldsaDFkWTlqazAyT0xzVDR0RkpLZXN2ZHRpRE83RTVqWk9TV2dtS1FTejhBYlBaMEpSRS1RMHl1SGlUMGNyQWp1T1JmMjVFeXNtUHJaamZQbw?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-09T23:13:14+00:00", "published_display": "09 Jul 2026 23:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb (BLCO) Could Be 57% Below Fair Value After Product Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOS2NZMWNDSHRSXzFqNmRqVjNOVGVCT1AxQ0lFaW1SNFdQVVppc3luMnJXQ3NFQXpVZGw5emNTTzlhdW5xa0hzTnh0WlBIOC1sNkpkbVJFVDNpSHZtMXhNRUQ0TnhvWmIyYXkzd3VWLW1KbjJfOGJmOFlZei1WcmVINUZuQ3dXMGtmdW9GZ1QzWll3VHM3?oc=5", "source_name": "Market source", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb sets July 29 call for Q2 2026 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOaFEzbS12dXh6X2o0anlvX1ZtSFFnazhueDI5bmFsUzBBQWpSUU9fbWtKck9RUThibkNwVGJxanFieUowZnFfdGViaFc2a3k2MklzV210QklkeF9MbVBoWGEyMkdlMWtUck53NndMVnlxaS0tSzI5R2xJUzBCTUxscHMtMGZWNk9mZ1N4WnNmNDNGTTZDUEhKYnVIUlJtZVlxamxrUmdMLThHT2pMQk9YcDBOWFZ0UUFhcG1xYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch & Lomb Earnings: Vision Care Resilience and Pharmaceutical Rebound Lead Off 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPRVAyOFdTYUlJVnJadm84clZaamJtOXdGZTU5Rm1uT2J6eWx1MFZTMVJ5NUI0bE93MlNaWlUxZms2SjdDLWZQeE9MaGR0cWVIa0NqQXNCOFdjQTFQZUFXS251TGxSMWNGUm5UOGVYYmYySGtuQ1QzdXRySFRoWEJuQUp6alo1OU1GaVBCUV9NelFUak1TdGhyVEpyaS1COE9LSXhtTzcyTGtHNGo0d0FnUDQ5TXJ0QWFydGdYSUtMUDJXZw?oc=5", "source_name": "Morningstar", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOb0ZWemZlT1UtTm9XVjdsZ3pONU54MXczTi1MN0p6NUIxVGdXTU1kZ25pbFprYjZlaEJWdC0tNkcwZU5SREoxWnQ3cjc4Slhmd1NEXzJkQkhMZkdLa2YyWDBuaE1ydHJORnR4NTcwemViOW5Bc2Z2M180LTFfbm5CWG9UYWdtRDAzcDBUZmpicndUaHozUFl6ZGN0UTZQUm8?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOYkdpQzMzQTktNEUwUFpMM0NyOVJvVDVUYVpKbnJPQ2l1YkxPdmFfTUMtZF96MUFrVmZKWXl5amtIRnFDcU9yVUp0cG0zRURFS0FmdnFVVFlKNmYyb0dzQ3JGdDZQdXRLT2lBZkEyWkhITlJwNEhZeC1kOFV6RUFBb0JUQXViUkdjcm5RZlpYUno2cmJkR3RhMA?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Bausch + Lomb (BLCO) After Its 28% One-Year Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQc3NiWDEyUjhSTUZhNVExeGg4OFJRMDZadDBGb2xJOVItMGVhc3dGbG90YmUzSGhyajBtQ0RodTY1MTlHejZXWHNwa2NiSWVhM2RaNFVlZ0ZSaFM0ck5EV0JBS2dvUUhOM20zQk40d2lnRVBhY0hlZ1o5VVFIXy13ZU5fYXI3eVpKam9mcGpEZTRLYXpuTzlkc2IzaFJEdw?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Bausch + Lomb (BLCO) Just Strengthened Something Beyond Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOU1pLXzFlZU10MloxMWIxUXU5YkRWeXNmWm1SRU01aDdkbU93R1FlQ1BMUXRmSHpSNVAtbkRyb001eGhiRzB3aHRoQy1TSy1Fem9oX3gwTGEtbERCbVZueFRyMklCZHpQR21MNXdvelRaRjFTczZtWS0xTWV4R0hrMUpYUDEtMTNzbk1IQ19GQ0g2eUhtdHd0Y3J3?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb brings full-range vision lens implant to Europe", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPUWozMmwyY2VNZ3VFODhMNGxldlY5WXpDTU9CcmtCQjhyZDFZVkVCenFfMGFtc09BdWgyVG41Z3QyNzJaZGszTWgxN25VNTg4dkd5MFpfaHVFdXRQdWlmcFE5NnhsbHR0VkJVMFRPalcyU0dtZE83b3hJdzAxM1pYUndrNllJZE1lT2FHdlpEQkdZWjZuSFFuV2s5YnFBTnpQVUFpUk4tN1BtNjR4V0pLazNmZTZOaWh5ZWZRNnh0a1c?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOelZmRXJOM2VuNDIwV1FiMWZsMzJtWXNqY3BISDNiRDFUd0FRS2lmNXVadkFlSmk5dGFHWU5RTFh6RzU1djBGcFI0N05NcmxkQl9lSl9UQTc1eEVKLXVZT0x0M3A4b2Vhb214ZXhfc1dyUUFuN3AyQjNpMk5SY0ZlOHRUQmk3ZEg2aUVsdEVmeVZuVDJaMks5QlB4V2YxYU1yMVZIMUJ1NWFiZFZjQXN0SXRxRUxVWjVZOXNRYlV3azN2am5XOVl1OUZaVWtLZDF3dFNjcERFMGZ5cUk?oc=5", "source_name": "Finviz", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch & Lomb Earnings: Nice Results from Growth Momentum, Solid Execution, and Pipeline Investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOR1ZVdGI1TmZuSm1LQldEVEplV3IzYS1hYnJVNURabjBoakktRUVjQndWZEVNRWNDSFB1YUh5ZkQ0akpDZkFELUM3UDVBbVdhOTNQWnY2ejRVMmtXTk1NdGotZlRJUVAtbmFzMjBfMDVJenUxYkhDbGhRYjlWcGZwUnA1WTgyMkhTYUItYTU4UkVsYV9HZ3JNR0lmeWRwTVc3N3hmYmpRYjdqQ0pJRHktVkpDNXNHRVZ2UGs5bDdnLUVNc1pTRVlRSQ?oc=5", "source_name": "Morningstar", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPOUFOWjBHOURnVnM0dXhMb3hBMG5FYW5Gakt2eVl2RVdkQklVZnNFNGFjM1A3a01tVnJNMkhJckdpSV81cXVkaXB3RjVRVFNtNFF6WG5PY1dyMjQ0b3BKdTd1VlNoRWtoWUxiWTdUV0RGZlA3Njg5TnVLTlI0eWVpdHIwZlppQjludURqSzlnc1A1QUh3M2J5RVItbjlQbXZVRk9fU05ucGZsZw?oc=5", "source_name": "Fierce Pharma", "published_at": "2024-12-12T08:00:00+00:00", "published_display": "12 Dec 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb Responds to Rumors of a Potential Sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNampxWUtHLW9oZnBsRUhSVnZRN2xTRkhsaktzVHYxM3dOT2NtZjd0eWV2S29UQ05mTkR6c210VnRHMUoxV1h3eldMYWNCZlQ1ckxiR0Z5RUlfWi1oOFluN1pXUE04QnFnbXdlLW8xVnowVDBIM2duV2lNejdZM1EtUGRzZVd1LUk1S3d3QjROSGlmNjZK?oc=5", "source_name": "BioSpace", "published_at": "2024-12-12T08:00:00+00:00", "published_display": "12 Dec 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Op-ed: Here\u2019s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC", "published_at": "2024-09-17T07:00:00+00:00", "published_display": "17 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Laval-based pharmaceutical company Bausch + Lomb plans US$788-million IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOYlZLc2RwdnRzbTFFczdxUG9WM1Y5R0JhWWVaQ3l1MFpJekZsMzExYURRdFBCZ3VoMDVyTHpIUDAxMEgyU0JINXh0V3dsTElqQUVlTl94bFhDYlVPcG8xTkJvUkdBVHFfTHpWSjY3XzhBV3B2UWQ5bThxcW9ZNk5LYlNpZF9oQURHcFZiWUdaVVRyakthZ1ktMlhKb2M2bENuWDI2bWx4RVN1ZnBEZlNqWkd0Uks0YTF5WWt0eA?oc=5", "source_name": "The Globe and Mail", "published_at": "2022-05-02T07:00:00+00:00", "published_display": "02 May 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Canadian company to buy Bausch + Lomb for $8.7B", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPWl9IYU5Wb3FNM0VpRFJaaHR4YUNmc3JuUFlCNXpwaVZBZkc0NjNQUWpSdWR5R1NsU0xkal8yQWNfdm84cG45bGN3Y20ydTZTaGdEdlR3cDBYNWRMSkk3TnctYVU5TEpVVTFMS2Zkdy10amdjSzlpblJuWUpsRWVFN0d3QnZDc3V3bl80NkxaNUY2S2tKOXBpVTh5VUhvS0Na?oc=5", "source_name": "NBC News", "published_at": "2013-05-27T07:00:00+00:00", "published_display": "27 May 2013 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "How Investors May Respond To Bausch + Lomb (BLCO) Expanding Ophthalmic Tools With EyeGility And Orphia AI", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-16T22:03:59+00:00", "published_display": "16 Jul 2026 22:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch + Lomb Corporation (BLCO) and Intellia Therapeutics (NTLA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgJBVV95cUxNTmhUeWZQRUVHWmlGVEdhLTdiUzUwbHd0aUN5OTljT2ZwWFVZa1NzVHJELVZuNU1ILV9feFItLXBtSElNZzY0elpSNUhKMXRnRENmamJGTElzNFloWFdYdlhwd05mSldpZ0JMaXFndHB5SHF0Z3owT1Z6QzdmRXJzRUZOTkNqWVJlbjRWbGdYX3RMNDRvNTVFZkhvMVh3UXNfbWc3NF9aanlPVzlYZVQ1a1I4UmQxOGhlS1RlYkhjdFozYTgtWXBCdVNtM2pTd2dNR3o1TlliRVd6dEVPUEZRMlBTM3pEWG9JUjNnbUdmRXhSdlN6eUZ3LVliZUdBZWtiemNuQlZaMmEzN1hWSEg3NEpORWFwZmNRWDJmTG1yYW5KdXZYRGtHRXRnclMwWmw0Z1NFTDZB?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-16T21:38:00+00:00", "published_display": "16 Jul 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $21", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQm9mSnZfcnNYZFRIcDhwWDdwUFQ4cU5fcDgtY2g3WTFHMlJkU2R4VktMWnA4d0NnTW5uRkpnTzYtM3RBVm5tblpWMEctM2pBUUhtV2hMNENfMkhZYXBCRGw3ZUVNWlZzbkFpcWd4Znl5Z0h0OTBIanlPZ1M1eENQUl9Bdk5wWElOX2tlT1hoaGFBdWxxSlpMTG1KR3ctRWJxbzVFRWg0X0x1QQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-15T21:31:00+00:00", "published_display": "15 Jul 2026 21:31", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb Corporation (BLCO) Stock Analysis: Examining a Healthcare Leader with 11.68% Potential Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxONjRqQVcyQ3ZUMHRIQjhoRjZ0WFdCLVoxR3lkV2lDV1R3RGdkQ2Y2WVpiNDltaWJYdk1CYTY4S2RKQ1R0VGtsLXR1VEprdy1UVFpTaVctTVdrQmtob3BNRVJHZWdoa0kyX2gyQ2ZXT2hwNS1rRy05V1RmcndWdU9IRGtaaE0wbjYzeUF2SzdjMEJnVDZKbmlldVZvOFFiYnFKaHdFSlp0TllEWlp0RVFXVjRxMVlCREVTbDJaOGNUd3JsSDY2aTY4Z19MZmh3c09XNnB4dlVqcjNrNldGSUluTFkzWjlCdEE?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:23:43+00:00", "published_display": "13 Jul 2026 09:23", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPYmtwbXNJUjlRc0owMHd3MDBQOFFhM1ppZWZmSkZVTVV0M1NVdDRKS2s5SDdaQndDZk81WHRXNTNZNGNVSHNPbVBQdURxdGhQSUxsLXRRRnZMZC1rSS1qXzMyUlFocTZ6TFA2OGNYSDBVeUtGUnpJWG1CZlRLV2U5ZmE0bWhIUGtmOXh6bExjZUlCanZJQ3c?oc=5", "source_name": "Market source", "published_at": "2026-07-10T21:27:20+00:00", "published_display": "10 Jul 2026 21:27", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BLCO Stock Drops After-Hours \u2014 Bausch + Lomb Halts Glaucoma Eye Drop Program After Trial Failure", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQcVR2TktPdTV5TFB1LXBsS0FiVklodV9kZlZsc0U1QTNyQ2dvT2lXa1NIZFlVRTZORGFDS21rNll4bDM2SC1GdWlXcm45TENtQnUwcVAyd1NwVnA0V1VmM255OXBwZUNGQmItWEMyakJsYnJxaDNoWUFud25XQzdiVldkZldsaDFkWTlqazAyT0xzVDR0RkpLZXN2ZHRpRE83RTVqWk9TV2dtS1FTejhBYlBaMEpSRS1RMHl1SGlUMGNyQWp1T1JmMjVFeXNtUHJaamZQbw?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-09T23:13:14+00:00", "published_display": "09 Jul 2026 23:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb (BLCO) Could Be 57% Below Fair Value After Product Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOS2NZMWNDSHRSXzFqNmRqVjNOVGVCT1AxQ0lFaW1SNFdQVVppc3luMnJXQ3NFQXpVZGw5emNTTzlhdW5xa0hzTnh0WlBIOC1sNkpkbVJFVDNpSHZtMXhNRUQ0TnhvWmIyYXkzd3VWLW1KbjJfOGJmOFlZei1WcmVINUZuQ3dXMGtmdW9GZ1QzWll3VHM3?oc=5", "source_name": "Market source", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb sets July 29 call for Q2 2026 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOaFEzbS12dXh6X2o0anlvX1ZtSFFnazhueDI5bmFsUzBBQWpSUU9fbWtKck9RUThibkNwVGJxanFieUowZnFfdGViaFc2a3k2MklzV210QklkeF9MbVBoWGEyMkdlMWtUck53NndMVnlxaS0tSzI5R2xJUzBCTUxscHMtMGZWNk9mZ1N4WnNmNDNGTTZDUEhKYnVIUlJtZVlxamxrUmdMLThHT2pMQk9YcDBOWFZ0UUFhcG1xYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch & Lomb Earnings: Vision Care Resilience and Pharmaceutical Rebound Lead Off 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPRVAyOFdTYUlJVnJadm84clZaamJtOXdGZTU5Rm1uT2J6eWx1MFZTMVJ5NUI0bE93MlNaWlUxZms2SjdDLWZQeE9MaGR0cWVIa0NqQXNCOFdjQTFQZUFXS251TGxSMWNGUm5UOGVYYmYySGtuQ1QzdXRySFRoWEJuQUp6alo1OU1GaVBCUV9NelFUak1TdGhyVEpyaS1COE9LSXhtTzcyTGtHNGo0d0FnUDQ5TXJ0QWFydGdYSUtMUDJXZw?oc=5", "source_name": "Morningstar", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOb0ZWemZlT1UtTm9XVjdsZ3pONU54MXczTi1MN0p6NUIxVGdXTU1kZ25pbFprYjZlaEJWdC0tNkcwZU5SREoxWnQ3cjc4Slhmd1NEXzJkQkhMZkdLa2YyWDBuaE1ydHJORnR4NTcwemViOW5Bc2Z2M180LTFfbm5CWG9UYWdtRDAzcDBUZmpicndUaHozUFl6ZGN0UTZQUm8?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOYkdpQzMzQTktNEUwUFpMM0NyOVJvVDVUYVpKbnJPQ2l1YkxPdmFfTUMtZF96MUFrVmZKWXl5amtIRnFDcU9yVUp0cG0zRURFS0FmdnFVVFlKNmYyb0dzQ3JGdDZQdXRLT2lBZkEyWkhITlJwNEhZeC1kOFV6RUFBb0JUQXViUkdjcm5RZlpYUno2cmJkR3RhMA?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Bausch + Lomb (BLCO) After Its 28% One-Year Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQc3NiWDEyUjhSTUZhNVExeGg4OFJRMDZadDBGb2xJOVItMGVhc3dGbG90YmUzSGhyajBtQ0RodTY1MTlHejZXWHNwa2NiSWVhM2RaNFVlZ0ZSaFM0ck5EV0JBS2dvUUhOM20zQk40d2lnRVBhY0hlZ1o5VVFIXy13ZU5fYXI3eVpKam9mcGpEZTRLYXpuTzlkc2IzaFJEdw?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Bausch + Lomb (BLCO) Just Strengthened Something Beyond Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOU1pLXzFlZU10MloxMWIxUXU5YkRWeXNmWm1SRU01aDdkbU93R1FlQ1BMUXRmSHpSNVAtbkRyb001eGhiRzB3aHRoQy1TSy1Fem9oX3gwTGEtbERCbVZueFRyMklCZHpQR21MNXdvelRaRjFTczZtWS0xTWV4R0hrMUpYUDEtMTNzbk1IQ19GQ0g2eUhtdHd0Y3J3?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb brings full-range vision lens implant to Europe", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPUWozMmwyY2VNZ3VFODhMNGxldlY5WXpDTU9CcmtCQjhyZDFZVkVCenFfMGFtc09BdWgyVG41Z3QyNzJaZGszTWgxN25VNTg4dkd5MFpfaHVFdXRQdWlmcFE5NnhsbHR0VkJVMFRPalcyU0dtZE83b3hJdzAxM1pYUndrNllJZE1lT2FHdlpEQkdZWjZuSFFuV2s5YnFBTnpQVUFpUk4tN1BtNjR4V0pLazNmZTZOaWh5ZWZRNnh0a1c?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOelZmRXJOM2VuNDIwV1FiMWZsMzJtWXNqY3BISDNiRDFUd0FRS2lmNXVadkFlSmk5dGFHWU5RTFh6RzU1djBGcFI0N05NcmxkQl9lSl9UQTc1eEVKLXVZT0x0M3A4b2Vhb214ZXhfc1dyUUFuN3AyQjNpMk5SY0ZlOHRUQmk3ZEg2aUVsdEVmeVZuVDJaMks5QlB4V2YxYU1yMVZIMUJ1NWFiZFZjQXN0SXRxRUxVWjVZOXNRYlV3azN2am5XOVl1OUZaVWtLZDF3dFNjcERFMGZ5cUk?oc=5", "source_name": "Finviz", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch & Lomb Earnings: Nice Results from Growth Momentum, Solid Execution, and Pipeline Investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOR1ZVdGI1TmZuSm1LQldEVEplV3IzYS1hYnJVNURabjBoakktRUVjQndWZEVNRWNDSFB1YUh5ZkQ0akpDZkFELUM3UDVBbVdhOTNQWnY2ejRVMmtXTk1NdGotZlRJUVAtbmFzMjBfMDVJenUxYkhDbGhRYjlWcGZwUnA1WTgyMkhTYUItYTU4UkVsYV9HZ3JNR0lmeWRwTVc3N3hmYmpRYjdqQ0pJRHktVkpDNXNHRVZ2UGs5bDdnLUVNc1pTRVlRSQ?oc=5", "source_name": "Morningstar", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPOUFOWjBHOURnVnM0dXhMb3hBMG5FYW5Gakt2eVl2RVdkQklVZnNFNGFjM1A3a01tVnJNMkhJckdpSV81cXVkaXB3RjVRVFNtNFF6WG5PY1dyMjQ0b3BKdTd1VlNoRWtoWUxiWTdUV0RGZlA3Njg5TnVLTlI0eWVpdHIwZlppQjludURqSzlnc1A1QUh3M2J5RVItbjlQbXZVRk9fU05ucGZsZw?oc=5", "source_name": "Fierce Pharma", "published_at": "2024-12-12T08:00:00+00:00", "published_display": "12 Dec 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb Responds to Rumors of a Potential Sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNampxWUtHLW9oZnBsRUhSVnZRN2xTRkhsaktzVHYxM3dOT2NtZjd0eWV2S29UQ05mTkR6c210VnRHMUoxV1h3eldMYWNCZlQ1ckxiR0Z5RUlfWi1oOFluN1pXUE04QnFnbXdlLW8xVnowVDBIM2duV2lNejdZM1EtUGRzZVd1LUk1S3d3QjROSGlmNjZK?oc=5", "source_name": "BioSpace", "published_at": "2024-12-12T08:00:00+00:00", "published_display": "12 Dec 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Op-ed: Here\u2019s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC", "published_at": "2024-09-17T07:00:00+00:00", "published_display": "17 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Laval-based pharmaceutical company Bausch + Lomb plans US$788-million IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOYlZLc2RwdnRzbTFFczdxUG9WM1Y5R0JhWWVaQ3l1MFpJekZsMzExYURRdFBCZ3VoMDVyTHpIUDAxMEgyU0JINXh0V3dsTElqQUVlTl94bFhDYlVPcG8xTkJvUkdBVHFfTHpWSjY3XzhBV3B2UWQ5bThxcW9ZNk5LYlNpZF9oQURHcFZiWUdaVVRyakthZ1ktMlhKb2M2bENuWDI2bWx4RVN1ZnBEZlNqWkd0Uks0YTF5WWt0eA?oc=5", "source_name": "The Globe and Mail", "published_at": "2022-05-02T07:00:00+00:00", "published_display": "02 May 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Canadian company to buy Bausch + Lomb for $8.7B", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPWl9IYU5Wb3FNM0VpRFJaaHR4YUNmc3JuUFlCNXpwaVZBZkc0NjNQUWpSdWR5R1NsU0xkal8yQWNfdm84cG45bGN3Y20ydTZTaGdEdlR3cDBYNWRMSkk3TnctYVU5TEpVVTFMS2Zkdy10amdjSzlpblJuWUpsRWVFN0d3QnZDc3V3bl80NkxaNUY2S2tKOXBpVTh5VUhvS0Na?oc=5", "source_name": "NBC News", "published_at": "2013-05-27T07:00:00+00:00", "published_display": "27 May 2013 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 68, "total_relevant": 22, "sentiment_summary": {"positive": 5, "negative": 1, "neutral": 16, "score": 54, "total": 22, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 8.05, "count": 14}, {"event": "earnings", "label": "Earnings", "weight": 4.55, "count": 7}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 5, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 22.89, "latest_week": "2026-07-10", "one_week_move": -6.8, "four_week_move": 8.5, "twelve_week_move": -1.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.076358, "market_dynamics_buy_signal": false, "relative_strength": -6.0717, "fair_value_gap": 3.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.9779, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.8% over one week, +8.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 7}, {"label": "The Globe and Mail", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "Morningstar", "count": 2}, {"label": "simplywall.st", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "DirectorsTalk Interviews", "count": 1}, {"label": "Stocktwits", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 22}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 14}, {"label": "Earnings", "count": 7}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "22", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.8% over one week, +8.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "How Investors May Respond To Bausch + Lomb (BLCO) Expanding Ophthalmic Tools With EyeGility And Orphia AI"}], "updated_at": "2026-07-18T09:39:39.646453+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}